Navigation Links
PharmMD Expands Advisory Board
Date:12/1/2008

NASHVILLE, Tenn., Dec. 1 /PRNewswire/ -- Medication therapy management (MTM) provider PharmMD recently added three accomplished professionals to its advisory board.

New members of the PharmMD advisory board include Martin Makary, M.D.; Michael Burcham; and Kevin Hutchinson. The three join an elite group of advisors that has helped PharmMD launch and hone its MTM services, which work to guard against medication error, misuse, overuse and abuse. MTM is proven to reduce the cost of providing drug benefits and improve the health of individual patients by taking measures to ensure they receive the most appropriate medications.

Martin Makary, M.D., is an active surgeon at The Johns Hopkins Hospital and professor for the university's Bloomberg School of Public Health. Dr. Makary currently serves in leadership roles for the United Nations World Health Organization (WHO), American College of Surgeons and International Union of Risk Management.

Michael Burcham most recently served as president of ParadigmHealth, a specialty care and disease management provider that integrates care and disease management services for health plan and employer clients. Prior to joining ParadigmHealth, Burcham founded and served as president of Theraphysics, a specialty rehabilitation firm. He began his career in healthcare with National HealthCorp and Hospital Corporation of America. Burcham is currently professor for the practice of management at the Owen Graduate School of Management at Vanderbilt University.

Kevin Hutchinson is president and CEO of Prematics, developer of the nation's first fully managed electronic medication prescribing solution. Prior to joining Prematics, Hutchinson was the founding president and CEO of SureScripts, where he led the effort to finance, build and deploy the Pharmacy Health Information Exchange, a national network for electronic prescribing and health information exchange.

PharmMD's other advisory board members include Gregg Lehman, Ph.D., president and CEO of Health Fitness Corporation; Dennis Delaney, executive vice president of human resources and administration for Ingram Industries; and Michael Hogue, Pharm.D., assistant professor of pharmacy practice at the McWhorter School of Pharmacy at Samford University in Birmingham, Ala.

"Medication-related health issues remain a critical problem both for insurers and for countless individuals across the country," said Bo Bartholomew, co-founder and CEO of PharmMD. "Our advisory board has offered invaluable counsel as we have fine-tuned our services and implemented our market strategy to address these issues. We are excited to welcome Martin, Michael and Kevin at such a strategic time in our company's development."

About PharmMD

PharmMD is an MTM provider based in Brentwood, Tenn., that works with employers and payers to help ensure that beneficiaries are receiving the most appropriate medications. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at www.pharmmd.com.


'/>"/>
SOURCE PharmMD
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PharmMD Announces Denise Kehoe as Vice President of Business Development
2. PharmMDs Brad Tice Named APhA Fellow
3. PharmMD Becomes an ASCP MTM Provider Partner
4. CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training
5. World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
6. Environmental and Technology Firm Integral Consulting Inc. Expands Services, Launches New Website
7. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
8. The SCOOTER Store Expands Power Mobility Products, Services to 7 Million Health Plan Members
9. Anpath Group, Inc. Expands International Distribution With Minntech Corporation
10. Baxa Expands its Automated Syringe Processing Capabilities
11. Crazy Water Expands Distribution to Whole Foods Market(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s Aresty Institute ... as a kick-off to the fifth annual CEO Connection Mid-Market Convention. , ... of Pennsylvania campus, followed by the two-day convention, which will target C-suite executives ...
(Date:6/28/2017)... Santa Clara, CA (PRWEB) , ... June 28, 2017 , ... ... is hosting a free AFM Luncheon for all SEMICONWest attendees and Park ... The luncheon will feature talks from Dr. Sang-il Park, Chairman & CEO of Park ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... and financial planning assistance to clients in southern Montana, is announcing a focused ... Zoo Montana. , The outreach programs offered by Zoo Montana provide students with ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers Insurance Agency, a ... northern Virginia and DC, is announcing a cooperative charity event in conjunction with ... other disorders that lead to memory impairment. , The Insight Memory Care Center ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... announced the appointment of Mike Finnegan to the position of Executive Vice President, ... of experience in healthcare technology, telehealth and medical device sales leadership. He has ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: